Evaluation of Novel Antimicrobial Hand Towels

In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9. The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections, self-reported fever, and skin infections in children <2 years old.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diarrheal Diseases Acute Respiratory Infections Body Temperature Changes Cellulitis Connective Tissue Diseases Fever Infections Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Signs and Symptoms Skin Diseases, Infectious Skin Infection Skin and Connective Tissue Diseases Suppuration

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2 / Phase 3

About this study

In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9. The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections (ARIs), self-reported fever, and skin infections in children <2 years old.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Mother of a child <2 years old

Exclusion criteria

Inaccessible enumeration area in the rainy season
Multiple eligible children in a single compound
Moved between census and round 1

Treatment and study plan

Antimicrobial Hand Towel

Other

Novel antimicrobial hand towel.

Primary outcomes

Number of participants with diarrheal disease

Time frame: Within 48 hours of enrollment

The number of participants that experience 3 or more loose or watery stools

Secondary outcomes

Number of participants with respiratory infections

Time frame: Within 48 hours of enrollment
Number of participants with a subjective fever

Time frame: Within 48 hours of enrollment
Number of participants with a skin infection

Time frame: Within 48 hours of enrollment

Sponsors and collaborators

Lead sponsor

Centers for Disease Control and Prevention

Fed

Registry information

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Jul 31, 2015
Registry last updated: Jul 31, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed